Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry
ContributorsGabay, Cem; Riek, Myriam; Scherer, Almut; Finckh, Axel
Published inRheumatology, vol. 54, no. 9, p. 1664-1672
Publication date2015
Abstract
Keywords
- Aged
- Antirheumatic Agents/therapeutic use
- Arthritis, Rheumatoid/drug therapy/epidemiology
- Biological Products/therapeutic use
- Comorbidity
- Disease Management
- Drug Therapy, Combination
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Proportional Hazards Models
- Quality of Health Care
- Registries
- Retrospective Studies
- Switzerland/epidemiology
- Treatment Outcome
Affiliation
Research group
Citation (ISO format)
GABAY, Cem et al. Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry. In: Rheumatology, 2015, vol. 54, n° 9, p. 1664–1672. doi: 10.1093/rheumatology/kev019
Main files (1)
Article (Published version)
Identifiers
- PID : unige:87960
- DOI : 10.1093/rheumatology/kev019
- PMID : 25922549
ISSN of the journal1462-0324